Cite
HARVARD Citation
Webb, T. (2018). Eukaryotic (translation) initiation factor 4A (eIF4A) inhibition may be used to treat Huntington's disease by decreasing the expression of huntingtin. Medical hypotheses. pp. 28-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Webb, T. (2018). Eukaryotic (translation) initiation factor 4A (eIF4A) inhibition may be used to treat Huntington's disease by decreasing the expression of huntingtin. Medical hypotheses. pp. 28-. [Online].